Compartilhar
Hematology, Transfusion and Cell Therapy
ISSN: 2531-1379
Hematology, Transfusion and Cell Therapy é uma publicação científica trimestral da Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Associazione Italo-Brasiliana di Ematologia (AIBE), Eurasian Hematology Oncology Group (EHOG) e Sociedade Brasileira de Oncologia Pediátrica (SOBOPE).
A Hematology, Transfusion and Cell Therapy publica artigos originais, artigos de revisão e relatos de caso relacionados com várias temáticas da área de hematologia e hemoterapia. Até 2017, a revista foi publicada sob o título Revista Brasileira de Hematologia e Hemoterapia.
ISSN print: 2531-1379
ISSN online: 2531-1387
Publicado por Elsevier Editora Ltda, Rio de Janeiro, Brasil.
Indexada em:
Scopus, Medline, Directory of Open Access Journals (DOAJ), PubMed Central (PMC), Emerging Sources Citation Index (ESCI), SCImago Journal Rank (SJR), SNIP
Ver maisSiga-nos:
Fator de impacto
O fator de impacto mede o número médio de citações recebidas em um ano por trabalhos publicados na revista durante os dois anos anteriores.
© Clarivate Analytics, Journal Citation Reports 2022
Fator de impacto 2023
1.8
Citescore
O CiteScore mede as citações médias recebidas por documento publicado. Mais informação
Ver maisCitescore 2023
2.4
SJR
SJR é uma métrica de prestígio baseada na idéia de que todas as citações não são iguais. SJR utiliza um algoritmo similar ao page rank do Google; é uma medida quantitativa e qualitativa ao impacto de uma publicação.
Ver maisSJR 2023
0.376
SNIP
SNIP permite comparar o impacto de revistas de diferentes campos temáticos, corrigindo as diferenças na probabilidade de ser citado que existe entre revistas de distintas matérias.
Ver maisSNIP 2023
0.565
Ver mais metricas
Ocultar
Número
Vol. 47. Núm. 1.(January - March 2025)
Original articles
Transmitted blood infections and emerging vector-borne diseases in blood donors in northern Portugal
Ana Mota, Margarida Fonseca Cardoso
Hematol Transfus Cell Ther. 2025;47:103734
Acesso de texto completo
Lower doses of dacarbazine (modified BEACODD) as a safer strategy with equal effectiveness in an intensive treatment protocol of Hodgkin's lymphoma: a preliminary retrospective analysis of a single public center in Brazil
Larissa Hilario Dulley, Arthur Gomes Oliveira Braga, Guilherme Garcia Rodrigues, Sergio Costa Fortier, Carlos Sérgio Chiattone, Talita Maira Bueno da Silveira
Hematol Transfus Cell Ther. 2025;47:3682
Acesso de texto completo
Is galactomannan a useful tool for triage and diagnosis of oral invasive aspergillosis?
Maria Júlia Pagliarone, Lara Maria Alencar Ramos Innocentini, Fernanda Bortolotto, Vanessa Tonetto Marques Galves, Hilton Marcos Alves Ricz, Tatiane Cristina Ferrari, Renato Luiz Guerino Cunha, Belinda Pinto Simões, Leandro Dorigan de Macedo
Hematol Transfus Cell Ther. 2025;47:3687
Acesso de texto completo
An approach to autologous stem cell mobilization: trying to define good mobilizers
Sara Montolio Chiva, Paula Gomez Fernandez, Antonio Manuel Gutiérrez Garcia, Maria del Carmen Ballester Ruiz, Antonia Sampol Mayol, Albert Perez Montaña
Hematol Transfus Cell Ther. 2025;47:3688
Acesso de texto completo
Validation of an automated quality control method to test sterility of two advanced therapy medicinal products: Mesenchymal stromal cells and their extracellular vesicles
Carolina Kymie Vasques Nonaka, Zaquer Suzana Munhoz Costa-Ferro, Ana Carolina Palmeira Arraes, Thamires Lopes Weber, Luciana Souza de Aragão França, Katia Nunes Silva, Bruno Solano de Freitas Souza
Hematol Transfus Cell Ther. 2025;47:3727
Acesso de texto completo
Effect of blood groups on acquired and congenital thrombotic thrombocytopenic purpura and clinical correlation: Multi-center Turkish cohort study
Cevat İlteriş Kıkılı, Damla Ortaboz, Melek Yanaşık, Muhlis Cem Ar, Sevgi Kalayoğlu Beşışık
Hematol Transfus Cell Ther. 2025;47:3723
Acesso de texto completo
Unraveling thalassemia intermedia: Novel insights of a hemoglobin Jax [HBA2:c.44G>C] and deletional α0-thalassemia interaction phenotype
Sitthichai Panyasai, Kanokwan Jaiping, Pisuttinee Khantarag, Patcharee Nochod, Surada Satthakarn
Hematol Transfus Cell Ther. 2025;47:103739
Acesso de texto completo
Twice or once a day? Filgrastim dosing schedule for peripheral hematopoietic stem cells mobilization
Mehmet Bakırtaş, Bahar Uncu Ulu, Tuğçe Nur Yiğenoğlu, Semih Başcı, Ali Kılınç, Tahir Darçın, Fatma Nurbüke Şarkışla, Derya Şahin, ... Fevzi Altuntaş
Hematol Transfus Cell Ther. 2025;47:103738
Acesso de texto completo
Evaluation of the role of serum soluble ST2 as a diagnostic biomarker for cancer-associated venous thromboembolism
Eman Mohamed Abdellatif, Emad Hamdy Hamouda Mohammed, Azza Mohamed Amin Darwish
Hematol Transfus Cell Ther. 2025;47:103740
Acesso de texto completo
Assessing the role of bronchoscopy in the management of patients with acute leukemia—a transversal study and proposal of evaluation
José Vanildo Rodrigues de Oliveira, Carlos Wilson de Alencar Cano, José Vivaldo Moreira Feitosa Júnior, Guilherme Carneiro Barreto, Fernanda Rodrigues Mendes, Raphael Costa Bandeira de Melo, Elvira Deolinda Rodrigues Pereira Velloso, Vanderson Rocha, ... Wellington Fernandes da Silva
Hematol Transfus Cell Ther. 2025;47:103741
Acesso de texto completo
Impact of blueberry extract on hematological response in phenylhydrazine-induced hemolytic anemia
Daniela Drosdowski, Patrick Türck, Silvio Tasca, Gabriel de Lima Rosa, Edson Fernando Muller Guzzo, Sara Elis Bianchi, Adriana Simon Coitinho, Cristina Campos Carraro, ... Alex Sander da Rosa Araujo
Hematol Transfus Cell Ther. 2025;47:103744
Acesso de texto completo
Case reports
STAT5B::RARα-positive acute promyelocytic leukemia: Role of next generation sequencing in detection of a rare malignancy
Indranil Dey, Sushant Vinarkar, Mayur Parihar, Deepak Kumar Mishra
Hematol Transfus Cell Ther. 2025;47:3726
Acesso de texto completo
Complex somatic mutation landscape in myeloid cells in a patient with VEXAS syndrome: First Brazilian case report
Fabíola Reis de Oliveira, Adriane Souza Lima, Carlos Roberto Faria, Thaise Oliveira Quaresma, Marcio M. Mourani, Lauro Wichert-Ana, Paulo Louzada, Fernanda Gutierrez-Rodrigues, ... Rodrigo T. Calado
Hematol Transfus Cell Ther. 2025;47:3686
Acesso de texto completo
Rare case of discrepant ABO typing between mother and newborn caused by para-Bombay AB phenotype
Tatiane Aparecida de Paula Vendrame, Giovana Faria Devides, Nayara Morais Silva, Marcela Custódio Mendes, Márcia Léia Morais Sampaio, Marcia Miyuki Nakamura, Greice Ap.Chetta de Klerk, Lilian Castilho, ... Carine Prisco Arnoni
Hematol Transfus Cell Ther. 2025;47:103742
Acesso de texto completo
Review articles
Ponatinib in the treatment of patients with chronic myeloid leukemia and increased cardiovascular risk: A review of management strategies
Tomasz Sacha, Katarzyna Krawczyk
Hematol Transfus Cell Ther. 2025;47:3675
Acesso de texto completo
When innovation meets patient blood management – a new way to see bleeding
Guilherme Rabello, Rosangela Monteiro, Bianca Meneghini, Fabio Biscegli Jatene
Hematol Transfus Cell Ther. 2025;47:3691
Acesso de texto completo
From the mechanism of action to clinical management: A review of cardiovascular toxicity in adult treated with CAR-T therapy
Frank Nunes, Breno Moreno de Gusmão, Franciely Bueno Wiginesk, Euler Manenti, Juliana Soares, Mizianne Garcia Freitas, Juliane Dantas Seabra-Garcez, Alexandre Manoel Varela, ... Ariane Vieira Scarlatelli Macedo
Hematol Transfus Cell Ther. 2025;47:3693
Acesso de texto completo
Letters to the editor
Assessing the contribution of myelofibrosis to a leukoerythroblastic blood picture
Stephen E. Langabeer
Hematol Transfus Cell Ther. 2025;47:103735
Acesso de texto completo
Imetelstat as a novel therapeutic approach for myelodysplastic syndrome
Ammara Waheed Arain, Anushka Andani, Aayat Kashif, Radeyah Waseem
Hematol Transfus Cell Ther. 2025;47:3724
Acesso de texto completo
Chronic lymphocytic leukemia diagnosis: how many more algorithms and scoring systems do we need?
Daniel Mazza Matos
Hematol Transfus Cell Ther. 2025;47:3668
Acesso de texto completo
Congenital thrombotic thrombocytopenic purpura and human leukocyte antigen analysis–an amazing clue
Cevat İlteriş Kıkılı, Demet Kıvanç, Hayriye Şentürk Çiftçi, Mustafa M. Özbalak, Mustafa N. Yenerel, Meliha Nalçacı, Fatma S. Oğuz, Sevgi K. Beşışık
Hematol Transfus Cell Ther. 2025;47:103746
Acesso de texto completo
Special content
Special Content
Images in clinical hematology
Dysmegakaryopoiesis in myelodysplastic syndrome: Beyond cell dysplasia
Maria Mirele da Silva Ribeiro, Francisco Dário Rocha Filho, Howard Lopes Ribeiro Junior, Priscila da Silva Mendonça, Ronald Feitosa Pinheiro, Silvia Maria Meira Magalhães
Hematol Transfus Cell Ther. 2025;47:3725
Acesso de texto completo
A rare case of circulating anaplastic lymphoma kinase-negative anaplastic large cell lymphoma
Radu Chiriac, Lucile Baseggio
Hematol Transfus Cell Ther. 2025;47:103743
Acesso de texto completo
Publicar em
Hematology, Transfusion and Cell Therapy
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.